Biofil Chemicals & Pharmaceuticals bulk deals, insider trading and stake changes
NSE: BIOFILCHEMBSE: 524396Pharmaceuticals & BiotechnologySmall Cap
Biofil Chemicals & Pharmaceuticals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1994 on BSE, Jun 1996 on NSE
Last close ₹28.68down ₹0.73 (2.48%)BSE ₹29.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹29.41.
30 Oct: open ₹29.00, high ₹29.80, low ₹28.26
52-week range of traded prices to 30 Oct 2026
₹25.60Low, 30 Mar 2026₹46.34High, 3 Feb 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹47 Cr3,363rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 96.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.16
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 2.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 2.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.14
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,71974.4% delivered
Biofil Chemicals & Pharmaceuticals' insiders have 27 trade disclosures on record, the latest on 20 Mar 2026. Its promoter group made no purchase or sale on the market in the 12 months to 30 Oct 2026.
Promoter and insider buying and selling
Trades made since 1 Nov 2025.Biofil Chemicals & Pharmaceuticals promoter holding
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade · 2 off-market moves
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Biofil Chemicals & Pharmaceuticals insider trading
Mar 2026
- MEENA SHAH32,657sharesReceived · Promoters · 18 Mar 2026 · disclosed 20 Mar · Inter-se-Transfer · stake 3.86% before, 4.06% after
- NIYATI SHAH32,657sharesGave · Promoters · 18 Mar 2026 · disclosed 20 Mar · Inter-se-Transfer · stake 4.25% before, 4.05% after
Jun 2025
- NIYATI SHAH₹0.17 Cr35,657 sharesSold or invoked · Promoter · 25 Jun 2025 · disclosed 27 Jun
- NIYATI SHAH₹0.32 Cr66,314 sharesSold or invoked · Promoter · 18 Jun 2025 · disclosed 20 Jun
- -Not statedOther · 10 Jun 2025
- RAMESH SHAH₹2.63 Cr4,93,940 sharesSold or invoked · Promoter And Designated Person · 6 Jun 2025 · disclosed 10 Jun
- Niyati Shah4,93,940sharesReceived · Promoter Group · 6 Jun 2025 · disclosed 9 Jun · Others · stake 1.84% before, 4.88% after
Mar 2024
- SANDEEP SHAH₹0.53 Cr87,200 sharesSold or invoked · Promoter · 15 Mar 2024 · disclosed 19 Mar
- MANALI SIMON₹0.53 Cr87,200 sharesBought · Promoter · 15 Mar 2024 · disclosed 19 Mar
- SANDEEP SHAH87,200sharesGave · Promoter Group · 11 Mar 2024 · Gift · stake 2.93% before, 2.40% after
- MANALI SIMON87,200sharesReceived · 11 Mar 2024 · Gift · holds 87,200 after, stake 0.53% after
Aug 2023
- SMITESH SANALAL SHAH₹0.39 Cr84,879 sharesSold or invoked · Promoter · 7 Aug 2023 · disclosed 12 Aug
- KETAN SHAH₹0.19 Cr42,440 sharesBought · Promoter And Designated Person · 7 Aug 2023 · disclosed 12 Aug
- MEENA SHAH₹0.19 Cr42,439 sharesBought · Promoter · 7 Aug 2023 · disclosed 12 Aug
- SANDEEP SHAH₹0.19 Cr42,440 sharesBought · Promoter · 7 Aug 2023 · disclosed 12 Aug
Jun 2023
- MEENA SHAH42,439sharesReceived · Promoter Group · 26 Jun 2023 · Gift · stake 3.60% before, 3.86% after
- KETAN SHAH42,440sharesReceived · Promoter Group · 26 Jun 2023 · Gift · stake 2.57% before, 2.83% after
- SMITESH SHAH1,27,319sharesGave · Promoter Group · 26 Jun 2023 · Gift · stake 1.75% before, 0.97% after
- SANDEEP SHAH42,440sharesReceived · Promoter Group · 26 Jun 2023 · Gift · stake 2.67% before, 2.93% after
Jun 2022
- MEENA SHAH₹2.13 Cr3,91,936 sharesBought · Promoter · 24 Jun 2022 · disclosed 23 Aug
- KETAN SHAH₹0.42 Cr77,165 sharesBought · Promoter And Designated Person · 24 Jun 2022 · disclosed 23 Aug
- SMITESH SANALAL SHAH₹4.34 Cr7,97,416 sharesSold or invoked · Promoter · 24 Jun 2022 · disclosed 23 Aug
- SANDEEP SHAH₹1.79 Cr3,28,315 sharesBought · Promoter · 24 Jun 2022 · disclosed 23 Aug
Mar 2022
2 entries
- Niyati Shah3,00,000sharesReceived · Immediate relative · 31 Mar 2022 · disclosed 1 Apr · Gift · holds 3,00,000 after, stake 1.84% after
- RAMESH SHAH3,00,000sharesGave · Promoters · 31 Mar 2022 · disclosed 1 Apr · Gift · stake 4.88% before, 3.04% after
Sep 2021
1 entry
- MEENA SHAH52,680sharesReceived · Promoter Group · 1 Sep 2021 · disclosed 6 Sep · Others · stake 0.86% before, 1.19% after
May 2017
1 entry
- RAMESH SHAH₹0.14 Cr1,40,620 sharesReceived · Key Managerial Personnel · 4 May 2017 · disclosed 6 May · Others · stake 4.01% before, 4.87% after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Biofil Chemicals & Pharmaceuticals stake sales and purchases
All 11 disclosures on record.
Mar 2024
- AcquiredManali Simon0.53% of the company87,200 sharesholds 0.53% after11 Mar 2024 · filed under the 2% rule
- SoldSandeep Shah · promoter0.54% of the company87,200 sharesholds 2.40% after11 Mar 2024 · filed under the 2% rule
Jun 2023
- AcquiredMeena Shah · promoter0.26% of the company42,439 sharesholds 3.86% after26 Jun 2023 · filed under the 2% rule · Inter-se transfer
- AcquiredSandeep Shah · promoter0.26% of the company42,440 sharesholds 2.93% after26 Jun 2023 · filed under the 2% rule · Inter-se transfer
- AcquiredKetan Shah · promoter0.26% of the company42,440 sharesholds 2.83% after26 Jun 2023 · filed under the 2% rule · Inter-se transfer
- SoldSmitesh Shah · promoter0.78% of the company1,27,319 sharesholds 0.97% after26 Jun 2023 · filed under the 2% rule · Inter-se transfer
Jul 2021
- SoldStarline Equifin Private Limited2.00% of the company3,25,800 sharesholds 9.37% after16 Jul 2021 · filed under the 2% rule · Open Market
- SoldStarline Equifin Private Limited2.00% of the company3,25,800 sharesholds 9.36% after16 Jul 2021 · filed under the 2% rule · Open Market
Jan 2021
- SoldLibra healthcare private limited1.66% of the company2,70,001 sharesholds 3.13% after6 Jan 2021 · filed under the 2% rule · Open Market
Dec 2020
- SoldLibra healthcare private limited0.43% of the company70,000 sharesholds 4.79% after3 Dec 2020 · filed under the 2% rule · Open Market
May 2017
- AcquiredRamesh Shah · promoter0.86% of the company1,40,620 sharesholds 4.88% after4 May 2017 · filed under the 2% rule · Inter-se transfer
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Biofil Chemicals & Pharmaceuticals bulk deals
Last 12 months, since 1 Nov 2025: 61 bulk deals, ₹10 Cr bought and ₹10 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Thursday 27 Aug 20261 firm · ₹0.30 Cr bought · ₹0.30 Cr soldNet nil
- Both waysORION STOCKS LTDBought 89,848 at ₹32.99Sold 89,848 at ₹32.930.55% of the companyNet nil₹0.30 Cr bought
Wednesday 26 Aug 20262 firms · ₹1.33 Cr bought · ₹1.33 Cr soldNet nil
- Both waysIRAGE BROKING SERVICES LLPBought 1,67,624 at ₹32.75Sold 1,67,624 at ₹32.591.03% of the companyNet nil₹0.55 Cr bought
- Both waysORION STOCKS LTDBought 2,41,206 at ₹32.57Sold 2,41,206 at ₹32.631.48% of the companyNet nil₹0.79 Cr bought
Tuesday 25 Aug 20262 firms · ₹1.98 Cr bought · ₹1.98 Cr soldNet nil
- Both waysORION STOCKS LTDBought 3,28,109 at ₹32.71Sold 3,28,109 at ₹33.012.02% of the companyNet nil₹1.07 Cr bought
- Both waysIRAGE BROKING SERVICES LLPBought 2,75,211 at ₹32.98Sold 2,75,211 at ₹32.721.69% of the companyNet nil₹0.91 Cr bought
Monday 24 Aug 20262 firms · ₹1.56 Cr bought · ₹1.56 Cr soldNet nil
- Both waysORION STOCKS LTDBought 2,68,391 at ₹32.09Sold 2,68,391 at ₹32.311.65% of the companyNet nil₹0.86 Cr bought
- Both waysIRAGE BROKING SERVICES LLPBought 2,16,009 at ₹32.18Sold 2,16,009 at ₹32.031.33% of the companyNet nil₹0.70 Cr bought
Monday 15 Jun 20261 firm · ₹0.32 Cr bought · ₹0.16 Cr soldNet bought ₹0.16 Cr
- Both waysORION STOCKS LTDBought 87,000 at ₹36.25Sold 43,120 at ₹36.420.53% of the companyNet +43,880 shares₹0.32 Cr bought
Friday 12 Jun 20262 firms · ₹1.13 Cr bought · ₹1.13 Cr soldNet nil
- Both waysORION STOCKS LTDBought 1,80,794 at ₹36.14Sold 1,80,794 at ₹36.381.11% of the companyNet nil₹0.65 Cr bought
- Both waysIRAGE BROKING SERVICES LLPBought 1,31,380 at ₹36.45Sold 1,31,380 at ₹36.120.81% of the companyNet nil₹0.48 Cr bought
Thursday 11 Jun 20262 firms · ₹1.42 Cr bought · ₹1.42 Cr soldNet nil
- Both waysORION STOCKS LTDBought 2,27,910 at ₹36.53Sold 2,29,273 at ₹36.581.41% of the companyNet −1,363 shares₹0.83 Cr bought
- Both waysIRAGE BROKING SERVICES LLPBought 1,60,661 at ₹36.45Sold 1,60,661 at ₹36.320.99% of the companyNet nil₹0.59 Cr bought
Wednesday 10 Jun 20262 firms · ₹1.14 Cr bought · ₹1.11 Cr soldNet bought ₹0.03 Cr
- Both waysORION STOCKS LTDBought 1,64,737 at ₹37.14Sold 1,56,274 at ₹37.341.01% of the companyNet +8,463 shares₹0.61 Cr bought
- Both waysIRAGE BROKING SERVICES LLPBought 1,40,526 at ₹37.38Sold 1,40,526 at ₹37.140.86% of the companyNet nil₹0.53 Cr bought
Friday 5 Jun 20261 firm · ₹0.41 Cr bought · ₹0.42 Cr soldNet nil
- Both waysORION STOCKS LTDBought 1,15,938 at ₹35.55Sold 1,15,938 at ₹35.810.71% of the companyNet nil₹0.41 Cr bought
Thursday 4 Jun 20261 firm · ₹0.19 Cr bought · ₹0.29 Cr soldNet sold ₹0.11 Cr
- Both waysORION STOCKS LTDBought 54,300 at ₹34.57Sold 84,624 at ₹34.650.52% of the companyNet −30,324 shares₹0.19 Cr bought
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. The latest 59 deals, on record from 4 Jan 2004.